This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19
ImmunoRankoffers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins